Strengths and prices
| Strength | Price per vial | Availability | Batch | |
|---|---|---|---|---|
| 10 mg | $21.00 | In stock | KPV-2607-0013 |
Every vial carries its batch code and a QR that opens the certificate of analysis for that exact batch. No account is needed to read one.
What it is
KPV is a tripeptide, lysine-proline-valine. It is the last three amino acids (positions 11 to 13) of alpha-melanocyte-stimulating hormone.
Identity
| Type | Synthetic peptide, 3 amino acids |
|---|---|
| Sequence | Lys-Pro-Val |
| Molecular formula | C16H30N4O4 |
| Molecular weight | 342.43 g/mol |
| CAS number | 67727-97-3 |
| PubChem CID | 125672 |
KPV is the linear tripeptide L-lysyl-L-prolyl-L-valine (Lys-Pro-Val), corresponding to residues 11 to 13 of alpha-MSH. Molecular formula C16H30N4O4, molecular weight 342.43 g/mol (PubChem CID 125672, CAS 67727-97-3). These figures describe the unmodified peptide with a free N-terminus and a free C-terminal carboxylic acid; in alpha-MSH itself the valine is amidated, and some published studies used acetylated or amidated variants, which have different masses. It contains no cysteine, methionine or aromatic residue, and the lysine side chain makes it a basic, water-soluble peptide. Mass spectrometry confirms the molecular mass, which distinguishes it from those variants, and HPLC reports purity. It is supplied as a lyophilized powder in a sealed vial.
What the published research covers
KPV has been studied in cell culture and in mouse models of intestinal inflammation, where its uptake by the peptide transporter PepT1 was described.
KPV is the C-terminal tripeptide of alpha-melanocyte-stimulating hormone (alpha-MSH), a 13-amino-acid peptide cut from the precursor pro-opiomelanocortin. Interest in the fragment began in the late 1980s at the University of Texas Southwestern Medical Center, where researchers studying the anti-inflammatory and antipyretic activity of alpha-MSH tested its last three residues alone and reported that they reduced chemically induced ear swelling in mice in proportion to the amount given (Hiltz, 1989).
Later work tried to explain how so short a peptide acts. In a mouse model of crystal-induced peritonitis, a London group found that KPV reduced the accumulation of neutrophils, but unlike alpha-MSH it did not raise cAMP in macrophages, its effect was not blocked by a melanocortin 3/4 receptor antagonist, and it persisted in mice without a functional MC1 receptor; the authors concluded that KPV is unlikely to act through melanocortin receptors (Getting, 2003). In 2008 a group at Emory University reported that KPV enters human intestinal epithelial cells and T cells through PepT1, a di- and tripeptide transporter that is induced in the colon during inflammatory bowel disease. At nanomolar concentrations it inhibited NF-kappaB and MAP kinase signaling in those cells, and given in drinking water it reduced inflammation in mice with chemically induced colitis (Dalmasso, 2008). A German group reported earlier recovery and less inflammatory infiltration of the colon in two mouse colitis models, including mice with a nonfunctional MC1 receptor (Kannengiesser, 2008). The Emory laboratory and its collaborators then loaded KPV into nanoparticles designed to release it in the colon and reported less mucosal damage in a mouse colitis model (Xiao, 2017).
All of this work is in cell culture and rodents, and much of the colitis literature comes from one laboratory and its collaborators. No clinical trial of KPV has been published in a peer-reviewed journal. Many recent reports test KPV inside a delivery system, such as nanoparticles or hydrogels, so their results do not necessarily describe the free peptide. Apart from its uptake by PepT1, the molecular target through which KPV reduces inflammatory signaling has not been identified.
Regulatory status
Not approved by the FDA for any use. Supplied for laboratory research only.
Testing and documentation
Identity is confirmed by mass spectrometry and purity by HPLC. The certificate of analysis for the batch is reachable from the code on the vial.
Questions laboratories ask
- What strength is KPV offered in?
- Vials of 10 mg, as listed on the product page. The amount is on the vial label and on the certificate of analysis for the batch.
- Is KPV the same as alpha-MSH?
- No. KPV is only the last three amino acids of alpha-melanocyte-stimulating hormone. Published studies report that it behaves differently from the full hormone and is unlikely to act through melanocortin receptors.
- How is a batch tested?
- By an independent laboratory: identity by mass spectrometry and purity by HPLC. The QR code on the vial opens the certificate of analysis for that exact batch; no account is needed to read it.
- Who can order, and how does it ship?
- Orders are accepted under the Research Use Agreement, reaffirmed with every order. Orders ship from Montana, the next business day when paid by card, to United States addresses only and not to freight forwarders.
References
- Hiltz ME et al. (1989). Antiinflammatory activity of a COOH-terminal fragment of the neuropeptide alpha-MSH. FASEB Journal. PubMed 2550304
- Getting SJ et al. (2003). Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides. Journal of Pharmacology and Experimental Therapeutics. PubMed 12750433
- Dalmasso G et al. (2008). PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. PubMed 18061177
- Kannengiesser K et al. (2008). Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflammatory Bowel Diseases. PubMed 18092346
- Xiao B et al. (2017). Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis. Molecular Therapy. PubMed 28143741
How it ships
Ordering
Ordering needs an account. A retail account opens as soon as you request it and costs nothing. You pay by card at checkout, or by invoice before the order ships. A wholesale account is reviewed before it opens.
Research use only
This product is a research chemical sold solely for in-vitro laboratory research by qualified persons. It is not a drug, food, supplement or cosmetic, has not been evaluated by the FDA, and must not be administered to any person or animal. Read the full agreement